"Kombiglyze XR (Type 2 Diabetes) - Analysis and Forecasts to 2020" Published
GlobalData's pharmaceuticals report, "Kombiglyze XR (Type 2 Diabetes) - Analysis and Forecasts to 2020" provides Kombilgyze XR sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Type 2 Diabetes market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website,...
View full press release